199 related articles for article (PubMed ID: 26453116)
1. HNRNPC as a candidate biomarker for chemoresistance in gastric cancer.
Huang H; Han Y; Zhang C; Wu J; Feng J; Qu L; Shou C
Tumour Biol; 2016 Mar; 37(3):3527-34. PubMed ID: 26453116
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
4. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
5. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Chang W; Guan W; Liu Y; Shen Q; Yu Y; Zhang H; Cao G
Cancer; 2013 Oct; 119(19):3436-45. PubMed ID: 23821160
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of drug resistant cell line of MGC-803 and analysis of differential secretome].
Huang H; Han Y; Wu J; Tian ZH; Qu LK; Shou CC
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):183-9. PubMed ID: 24743803
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer.
Wang J; Zhang J; Liu H; Meng L; Gao X; Zhao Y; Wang C; Gao X; Fan A; Cao T; Fan D; Zhao X; Lu Y
Cancer Commun (Lond); 2024 Apr; 44(4):469-490. PubMed ID: 38512764
[TBL] [Abstract][Full Text] [Related]
8. Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.
Wang J; Xu R; Li J; Bai Y; Liu T; Jiao S; Dai G; Xu J; Liu Y; Fan N; Shu Y; Ba Y; Ma D; Qin S; Zheng L; Chen W; Shen L
Gastric Cancer; 2016 Jan; 19(1):234-44. PubMed ID: 25604851
[TBL] [Abstract][Full Text] [Related]
9. HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer.
Xia N; Yang N; Shan Q; Wang Z; Liu X; Chen Y; Lu J; Huang W; Wang Z
J Cell Mol Med; 2022 Apr; 26(8):2322-2336. PubMed ID: 35277915
[TBL] [Abstract][Full Text] [Related]
10. Transcription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.
Sun J; Du N; Li J; Zhou J; Tao G; Sun S; He J
Technol Cancer Res Treat; 2016 Apr; 15(2):285-95. PubMed ID: 25810491
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
12. TFAP2E methylation promotes 5‑fluorouracil resistance via exosomal miR‑106a‑5p and miR‑421 in gastric cancer MGC‑803 cells.
Jingyue S; Xiao W; Juanmin Z; Wei L; Daoming L; Hong X
Mol Med Rep; 2019 Jul; 20(1):323-331. PubMed ID: 31115533
[TBL] [Abstract][Full Text] [Related]
13. Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil.
Han JH; Kim M; Kim HJ; Jang SB; Bae SJ; Lee IK; Ryu D; Ha KT
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065602
[TBL] [Abstract][Full Text] [Related]
14. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
[TBL] [Abstract][Full Text] [Related]
15. [GRP78 expression in gastric cancer and its clinical significance].
Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer.
Mutze K; Langer R; Schumacher F; Becker K; Ott K; Novotny A; Hapfelmeier A; Höfler H; Keller G
Eur J Cancer; 2011 Aug; 47(12):1817-25. PubMed ID: 21458988
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line.
Peri S; Biagioni A; Versienti G; Andreucci E; Staderini F; Barbato G; Giovannelli L; Coratti F; Schiavone N; Cianchi F; Papucci L; Magnelli L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299320
[TBL] [Abstract][Full Text] [Related]
19. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
[TBL] [Abstract][Full Text] [Related]
20. Alpha 7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to 5-fluorouracil.
Chen WY; Huang CY; Cheng WL; Hung CS; Huang MT; Tai CJ; Liu YN; Chen CL; Chang YJ
Tumour Biol; 2015 Dec; 36(12):9537-44. PubMed ID: 26136123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
